GlassScriptPhysician profile
Nicolaas Grobler
NPI 1720154255
$9,775.53
in general payments reported to CMS, 2019-2025
46 companies · $2,628 in 2025
The $2,628 reported for 2025 was more than what 81% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $805 · 2020: $299 · 2021: $656 · 2022: $1,242 · 2023: $2,278 · 2024: $1,869 · 2025: $2,628.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,590 · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,589.88 |
| Education | $184.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,841.20 | 2019-2025 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $816.57 | 2019-2025 | Fasenra, Tezspire, Breztri |
| Regeneron Healthcare Solutions, INC. | $600.80 | 2022-2025 | Dupixent |
| Genzyme Corporation | $548.92 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $391.89 | 2019-2025 | Jardiance, Ofev, Jascayd |
| Bayer Healthcare Pharmaceuticals INC. | $330.75 | 2019-2024 | |
| Exact Sciences Corporation | $325.09 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $310.64 | 2021-2025 | Ozempic, Rybelsus |
| Octapharma USA, INC. | $291.06 | 2023-2024 | Cutaquig, Panzyga |
| Pfizer INC. | $277.04 | 2020-2024 | |
| Merck Sharp & Dohme LLC | $271.82 | 2024-2025 | Winrevair |
| Sanofi-Aventis U.S. LLC | $225.95 | 2020-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $193.87 | 2021-2023 | Xifaxan |
| Verona Pharma, INC. | $169.80 | 2025 | Ohtuvayre |
| Inari Medical, INC. | $168.50 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $162.71 | 2021-2022 | |
| Insmed, INC. | $162.08 | 2023-2025 | Arikayce, Brinsupri |
| Lilly USA, LLC | $145.46 | 2023-2025 | Jardiance, Zepbound, Mounjaro |
| Janssen Pharmaceuticals, INC | $144.30 | 2023-2024 | Xarelto |
| Cleerly, INC. | $138.14 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Actelion Pharmaceuticals US, INC. | $110.85 | 2019-2024 | Uptravi, Opsumit |
| Baxter Healthcare | $100.36 | 2023-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Volara System, Hillrom - Monarch Airway Clearance System |
| Sunovion Pharmaceuticals INC. | $92.12 | 2019-2020 | |
| Amgen INC. | $86.46 | 2024-2025 | Repatha, Repatha, Otezla |
| Inspire Medical Systems, INC. | $86.35 | 2025 | Inspire |
| United Therapeutics Corporation | $82.37 | 2019-2024 | Tyvaso, Orenitram |
| Electromed, INC. | $81.77 | 2023-2025 | Smartvest |
| Genentech USA, INC. | $67.21 | 2023 | Xolair |
| Xeris Pharmaceuticals, INC. | $61.08 | 2024-2025 | Gvoke Hypopen |
| Shionogi INC | $60.34 | 2021-2024 | Fetroja |
| Novartis Pharmaceuticals Corporation | $53.16 | 2025 | |
| Phadia US INC. | $45.95 | 2024 | Immunocap |
| Otsuka America Pharmaceutical, INC. | $44.70 | 2019 | |
| Philips North America LLC | $43.48 | 2019-2024 | (8874) Incourage |
| Paratek Pharmaceuticals, INC. | $34.85 | 2023 | Nuzyra |
| Sumitomo Pharma America, INC. | $32.65 | 2024 | Gemtesa |
| Dexcom, INC. | $23.02 | 2025 | Dexcom G6 Transmitter |
| Viatris Specialty LLC | $20.57 | 2025 | Yupelri |
| Antares Pharma, INC. | $18.53 | 2021 | |
| Inogen, INC. | $18.44 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Almatica Pharma LLC | $18.21 | 2022 | |
| Gilead Sciences, INC. | $17.61 | 2025 | Veklury |
| Shield Therapeutics INC | $16.73 | 2022 | |
| Abbott Laboratories | $15.98 | 2025 | Freestyle Libre 3 |
| Melinta Therapeutics, LLC | $13.67 | 2019 | |
| La Jolla Pharmaceutical Company | $12.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicolaas Grobler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.